Nyheter

SPRINT BIOSCIENCE LICENSES THE CANCER DRUG PROGRAM VPS34 TO DECIPHERA PHARMACEUTICALS

Sprint Bioscience AB (publ) announces today that the company has licensed its cancer drug program Vps34 to the US pharmaceutical company Deciphera Pharmaceuticals. The license agreement covers exclusive global rights to the program. The agreement has a total potential value of up to USD 277 million, plus additional tiered percentage royalties ranging from the mid-single-digits […]
Read More

HUMBLE ACQUIRES NATY, A WORLD-LEADING FMCG-COMPANY AND BRAND WITHIN ENVIRONMENTALLY FRIENDLY DIAPERS AND PERSONAL CARE PRODUCTS

Humble Group AB (publ) (“Humble”) has signed a binding agreement with the owners of Naty AB (”Naty or ”the Company”) regarding the acquisition of all shares in the Company (”the Transaction”). The total purchase price amounts to a maximum of SEK 850 million and is comprised of a fixed remuneration of SEK 750 million (”the […]
Read More

Humble Group contemplates issuance of new senior secured bonds of SEK 700m under a framework amount of SEK 1,500m and initiates a written procedure to amend the terms and conditions of existing bonds

Humble Group AB (publ) (“Humble Group” or the “Company”) has mandated Carnegie Investment Bank as Sole Bookrunner to arrange a series of investor calls with selected Nordic fixed income investors to explore the conditions for the Company to issue senior secured bonds in the expected amount of SEK 700,000,000 under a framework amount of SEK […]
Read More

HUMBLE FÖRVÄRVAR EWALCO, EN LEDANDE FOODTECH-KONCERN

Humble Group AB (publ) (“Humble”) har tecknat bindande avtal med ägarna av koncernen Ewalco Holding AB (”Ewalco eller ”Bolaget”) avseende förvärv av samtliga aktier i Bolaget (”Transaktionen”). Köpeskillingen uppgår till en fast ersättning om 110 miljoner kronor (”Köpeskillingen”) samt tilläggsköpeskillingar baserade på framtida EBITDA-resultat. Av Köpeskillingen ska 55 miljoner kronor erläggas kontant och resterande 55 […]
Read More

Fredrik Paulún tillträder som VD på Nutribe AB

Näringsfysiologen Fredrik Paulún blir 1/6 2021 VD för Nutribe AB. Han värvades tack vare sin djupgående kunskap inom entreprenörskap och hälsa. Fredrik säger ”Näringslära är mitt stora intresse, levebröd och livsstil, och jag har spenderat de senaste tre decennierna med att hjälpa allmänheten äta nyttigare. Till min hjälp har jag haft böcker, mässor, föreläsningar, kostrådgivning och […]
Read More

Humble acquires two companies – Nordfood and Be:Son

Humble Group AB (publ) (“Humble”) has through the subsidiary Green Sales NewCo AB signed a binding agreement with the owners of Nordfood AB (“Nordfood”) and Be:Son Gross AB (“Be:Son” and together with Nordfood, “the Companies”) regarding the acquisition of all of the shares in the Companies (“the Transactions”). The purchase price amounts to 62 million […]
Read More

Humble acquires Wellibities – Takes a leading position in healthy sweets

Humble Group AB (publ) (“Humble”) has entered into a binding agreement with the owner of Wellibites AB (“Wellibites” or the “Company”) regarding the acquisition of all the shares in the Company. Wellibites is a fast-growing company and leading brand within sugar-free and vitamin-enriched sweets. Since the launch, the company has experienced strong growth with good […]
Read More

Sprint Bioscience presenterar bolag och projekt för investerare och internationella läkemedelsbolag

Sprint Biosience AB (publ) meddelar bolagets närmaste planer för digitala investermöten samt ett internationellt partneringmöte. Aktiespararnas Småbolagsdagar, 7-8 juni Aktiesparnas årliga småbolagsdagar innehåller bolagspresentationer, utbildningsinslag, paneldebatter och intervjuer. Möjlighet ges att digital ta del av vd Erik Kinnsmans presentation av bolaget via film och streaming. Mer information kommer att finnas här: https://www.aktiespararna.se/smabolagsdagarna BIO International Convention Digital, 14–18 […]
Read More